Endoscopic Mucosal Resection and Cellular Matrix

Overview

About this study

This study is being done to assess the use of scaffold products in promoting constructive healing as determined by the ability of the resection site to lift during follow-up.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • 18 and older
  • Male or female
  • Able to provide consent
  • Scheduled for standard of care endoscopy that may require initial EMR evaluation of esophageal lesions
  • Histological evidence of intestinal metaplasia with dysplasia or intramucosal carcinoma

Exclusion Criteria

  • Pregnant women
  • Age less than 18
  • Prior esophageal EMR or ESD in the same region
  • Anyone unable to provide informed consent
  • Medical co-morbidities precluding EGD evaluation
  • History of chemoradiotherapy to the neck/esophagus
  • Unable to stop anticoagulation therapy (non-steroid anti-inflammatory medications are permissible)

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Kenneth Wang, M.D.

Open for enrollment

Contact information:

Lori Lutzke CCRP

(507)255-7495

Lutzke.Lori@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available